Express Pharma

India an emerging hub for biologics and biosimilars: Report

The report examines the transformation of the pharmaceutical/biotech industry from small molecule therapeutics to biotherapeutics (biologics and biosimilars), driven by unmet clinical needs, the inherent advantages of biotherapeutics, and commercial potential

0 351